- Home
- Peg-Adrim 50Mg/25Ml Inj
Peg-Adrim 50Mg/25Ml Inj Substitute
Peg-Adrim 50Mg/25Ml Inj Substitute
All Substitutes & Brand Comparisons
RX
DOXUTEC 50MG INJECTION 25ML
United Biotech Pvt Ltd
₹951.5
(₹34.26/ 1ml)
94% CHEAPERRX
Adrib 50 mg Injection 25 ml
Adley Formulations
₹985
(₹35.46/ 1ml)
94% CHEAPERRX
Lippod 50 mg Injection 25 ml
Celon Laboratories Pvt Ltd
₹9460
(₹310.29/ 1ml)
53% CHEAPERRX
Pegadria 50 Injection 25 ml
Intas Pharmaceuticals Ltd
₹9460
(₹310.29/ 1ml)
53% CHEAPERRX
Metodox 50 mg Injection 1's
Neon Laboratories Ltd
₹398
(₹358.2 per unit)
45% CHEAPERRX
Nudoxa 50Mg/ 25Ml Inj
Zydus Cadila
₹14493
(₹475.37/ 1ml)
28% CHEAPERRX
Doxulip 50 Injection 25 ml
United Biotech Pvt Ltd
₹19230
(₹630.74/ 1ml)
4% CHEAPERRX
Adriamycin 50 mg Injection 1's
Pfizer Ltd
₹847.5
(₹745.8 per unit)
12% COSTLIERRX
Doxotero 50 mg Injection 1's
Hetero Healthcare Pvt Ltd
₹831.5
(₹748.4 per unit)
13% COSTLIERRX
ADRIM 50MG INJECTION
Dabur India Ltd
₹847.5
(₹762.8 per unit)
15% COSTLIERRX
Oncodox 50 mg Injection 1's
Cipla Ltd
₹773.3
(₹773.3 per unit)
16% COSTLIERRX
Orcamycin 50Mg Injection
Orca Healthcare Pvt Ltd
₹900
(₹810.0 per unit)
22% COSTLIERRX
Adrimos 50 mg Injection 1's
Oncostar Pharma Pvt Ltd
₹880
(₹880.0 per unit)
32% COSTLIERRX
Doxybenz-50 Injection 1's
Admac Lifesciences(Oncology)
₹929
(₹929.0 per unit)
40% COSTLIERRX
Doxilyd 50 mg Injection 1's
Celon Laboratories Pvt Ltd
₹1212.5
(₹1091.3 per unit)
64% COSTLIER
Verified Ingredients and Effects
Composition:
DOXORUBICIN-50MG
Uses:
Breast Cancer
Medicinal Benefits:
Peg-Adrim 50Mg/25Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Peg-Adrim 50Mg/25Ml Inj is also used in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumour, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma
FAQs
Peg-Adrim 50Mg/25Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis.
Peg-Adrim 50Mg/25Ml Inj can disrupt a woman's natural menstrual cycle (period) and inhibit sperm production in men. However, you should not presume that you cannot become pregnant or that you cannot make someone else pregnant. It may also harm your foetus. Use reliable methods of birth control while on treatment with Peg-Adrim 50Mg/25Ml Inj.
